Yes, absolutely get the flu shot—it's a Class I recommendation for all heart failure patients and may reduce your risk of death by 25-40%.
Patients with severe heart failure (LVEF 15%) should receive annual influenza vaccination as a critical component of their cardiovascular care, with the same priority given to other life-saving therapies like beta-blockers and ACE inhibitors. 1
Why This Matters for Severe Heart Failure
Your severely reduced ejection fraction (15%) places you at exceptionally high risk for complications from influenza infection. The virus triggers:
- Systemic inflammation that directly stresses your already-compromised heart
- Increased metabolic demands your weak heart cannot meet
- Prothrombotic states raising risk of clots and acute events
- Pulmonary congestion worsening your breathing 2
Influenza-related death is more common among individuals with cardiovascular disease than among patients with any other chronic condition 1
The Evidence for Mortality Benefit
The data supporting vaccination in heart failure is robust:
- Randomized trial data shows cardiovascular mortality reduction to 0.25 (meaning 75% lower risk of cardiac death at 1 year) in vaccinated versus unvaccinated patients 1
- Recent meta-analysis (2023) of 9,340 high-risk cardiac patients demonstrated:
- 26% reduction in composite cardiovascular events (HR 0.74)
- 37% reduction in cardiovascular death (HR 0.63)
- 28% reduction in all-cause death (HR 0.72) 3
- Observational studies in heart failure specifically show 17-23% reduction in all-cause mortality 4, 5
Guideline Recommendations
The American Heart Association and American College of Cardiology issue a Class I, Level B recommendation for influenza vaccination in all patients with cardiovascular disease, including heart failure 1. This is the strongest level of recommendation—meaning the benefits far outweigh any risks, and it should be done routinely.
Which Vaccine to Choose
Consider high-dose influenza vaccine (HD-IIV) over standard-dose if you're ≥65 years old. The 2025 DANFLU-2 trial (the largest individually randomized influenza vaccine trial ever conducted with 332,438 participants) showed that in heart failure patients, high-dose vaccine was associated with:
- 45% lower risk of influenza hospitalization (RR 0.55)
- 18% lower risk of heart failure hospitalization (RR 0.82)
- Similar benefits regardless of disease severity, recent hospitalization, or NT-proBNP levels 6
If you're under 65, standard inactivated vaccine (intramuscular) is appropriate. Do not use live attenuated nasal vaccine—it's not recommended for cardiovascular patients 1.
Timing and Practical Considerations
- Get vaccinated before flu season (September-November ideally) 5
- If recently hospitalized, vaccination at hospital discharge is highly effective and cost-saving, preventing 44 deaths per 1,000 patients over 12 months 7
- Don't wait—only 34% of heart failure patients nationally receive the vaccine, far below the 90% goal 1
Common Pitfalls to Avoid
- Don't skip vaccination thinking your heart is "too weak"—there's no evidence of harm, only benefit 1
- Don't assume your cardiologist will offer it—about half of cardiology practices don't stock vaccine 1. Ask your primary care doctor or go to a pharmacy
- Don't delay if you've had recent decompensation—vaccination during or shortly after hospitalization is safe and particularly beneficial 6, 7
The Bottom Line
With an LVEF of 15%, you're in the highest-risk category for influenza complications. Vaccination is as important as your other heart failure medications and could reduce your risk of dying by up to one-third. This is a no-brainer intervention that's safe, inexpensive, and potentially life-saving.